Pten mutations alter brain growth trajectory and allocation of cell types through elevated β-Catenin signaling

Journal of Neuroscience

Volumn 35, Issue 28, 2015, Pages 10252-10267

  Chen, Youjun ^a   Huang, Wen Chin ^a   Séjourné, Julien ^a   Clipperton Allen, Amy E ^a   Page, Damon T ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autism; Brain growth; Cell types; Macrocephaly; Pten; catenin

Indexed keywords

BETA CATENIN; GENOMIC DNA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; CARRIER PROTEIN; CELL CYCLE PROTEIN; CTIP PROTEIN, MOUSE; EMPTY SPIRACLES HOMEOBOX PROTEINS; HOMEODOMAIN PROTEIN; MTOR PROTEIN, MOUSE; NERVE PROTEIN; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN CORTEX; BRAIN GROWTH; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE MUTATION; GENOTYPING TECHNIQUE; GERMLINE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANIMAL EMBRYO; BRAIN; C57BL MOUSE; CELL CYCLE; CONGENITAL MALFORMATION; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLIA; GROWTH, DEVELOPMENT AND AGING; HAPLOINSUFFICIENCY; METABOLISM; NERVE CELL; NEWBORN; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BETA CATENIN; BRAIN; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION; HAPLOINSUFFICIENCY; HOMEODOMAIN PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS;

EID: 84937605418     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5272-14.2015     Document Type: Article

References (72)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797-3804. CrossRef Medline
2. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111-2115. CrossRef Medline
3. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, MakTW (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29:396-403. CrossRef Medline
4. Bonaguidi MA, Wheeler MA, Shapiro JS, Stadel RP, Sun GJ, Ming GL, Song H (2011) In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell 145:1142-1155. CrossRef Medline
5. Boylan CB, Blue ME, Hohmann CF (2007) Modeling early cortical serotonergic deficits in autism. Behav Brain Res 176:94 -108. CrossRef Medline
6. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R (2001) Inactivation of the betacatenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128: 1253-1264. Medline
7. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42:318 -321. CrossRef Medline
8. Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C (2007) Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 144B:484-491. CrossRef Medline
9. Carper RA, Courchesne E (2005) Localized enlargement of the frontal cortex in early autism. Biol Psychiatry 57:126 -133. CrossRef Medline
10. Carper RA, Moses P, Tigue ZD, Courchesne E (2002) Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage 16:1038- 1051. CrossRef Medline
11. Chenn A, WalshCA (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365-369. CrossRef Medline
12. Chow ML, Pramparo T, Winn ME, Barnes CC, Li HR, Weiss L, Fan JB, Murray S, April C, Belinson H, Fu XD, Wynshaw-Boris A, Schork NJ, Courchesne E (2012) Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet 8:e1002592. CrossRef Medline
13. Chung JH, Eng C (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65:8096-8100. CrossRef Medline
14. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205. CrossRef Medline
15. Clipperton-Allen AE, Page DT (2014) Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. Hum Mol Genet 23:3490 -3505. CrossRef Medline
16. Courchesne E (2002) Abnormal early brain development in autism. Mol Psychiatry 7[Suppl 2]:S21-S23.
17. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, Morgan J (2007) Mapping early brain development in autism. Neuron 56:399-413. CrossRef Medline
18. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306:2001-2010. CrossRef Medline
19. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789. CrossRef Medline
20. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE (2012) Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367:1921-1929. CrossRef Medline
21. Diao L, Chen YG (2007) PTEN, a general negative regulator of cyclin D expression. Cell Res 17:291-292. CrossRef Medline
22. Dubruc E, Putoux A, Labalme A, Rougeot C, Sanlaville D, Edery P (2014) A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. Am J Med Genet A 164A:1571-1575. CrossRef Medline
23. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16: 2259-2264. CrossRef Medline
24. Edmonson C, Ziats MN, Rennert OM (2014) Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum. Mol Autism 5:3. CrossRef Medline
25. Fang WQ, Chen WW, Jiang L, Liu K, Yung WH, Fu AK, Ip NY (2014) Overproduction of upper-layer neurons in the neocortex leads to autismlike features in mice. Cell Rep 9:1635-1643. CrossRef Medline
26. Ferrer-Vaquer A, Piliszek A, Tian G, Aho RJ, Dufort D, Hadjantonakis AK (2010) A sensitive and bright single-cell resolution live imaging reporter of Wnt/β-catenin signaling in the mouse.BMCDev Biol 10:121. CrossRef Medline
27. Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ (2004) Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 64:7773-7779. CrossRef Medline
28. Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C (2014) Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry. Advance online publication. Accessed Oct. 7, 2014. doi: 10.1038/mp.2014.125. CrossRef Medline
29. Goberdhan DC, Paricio N, Goodman EC, Mlodzik M, Wilson C (1999) Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev 13: 3244-3258. CrossRef Medline
30. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR (2002) Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci 22:6309-6314. Medline
31. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X, Wu H (2001) Negative regulation of neural stem/ progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294:2186 -2189. CrossRef Medline
32. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11:859-871. CrossRef Medline
33. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J (2005) Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry 62: 1366-1376. CrossRef Medline
34. Herculano-Houzel S, Lent R (2005) Isotropic fractionator: a simple, rapid method for the quantification of total cell and neuron numbers in the brain. J Neurosci 25:2518 -2521. CrossRef Medline
35. Huang W, Chang HY, Fei T, Wu H, Chen YG (2007) GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 26:2471-2482. CrossRef Medline
36. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S (1996) A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys ResCommun 224:855- 862. CrossRef Medline
37. Kanner L (1943) Autistic disturbances of affective contact. Nervous Child 2:217-250.
38. Kazdoba TM, Sunnen CN, Crowell B, Lee GH, Anderson AE, D'Arcangelo G (2012) Development and characterization of NEX- Pten, a novel forebrain excitatory neuron-specific knockout mouse. Dev Neurosci 34:198- 209. CrossRef Medline
39. Klein S, Sharifi-Hannauer P, Martinez-Agosto JA (2013) Macrocephaly as a clinical indicator of genetic subtypes in autism. Autism Res 6:51-56. CrossRef Medline
40. Kriegstein A, Alvarez-Buylla A (2009) The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32:149-184. CrossRef Medline
41. KwonCH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ (2001) Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29:404-411. CrossRef Medline
42. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X,WuH (2002) Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32:148 -149. CrossRef Medline
43. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947. CrossRef Medline
44. Li L, Liu F, Salmonsen RA, Turner TK, Litofsky NS, Di Cristofano A, Pandolfi PP, Jones SN, Recht LD, RossAH (2002) PTENin neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci 20:21-29. CrossRef Medline
45. McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, Herman GE (2010) Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 3:137-141. CrossRef Medline
46. Migheli A, Cordera S, Bendotti C, Atzori C, Piva R, Schiffer D (1999) S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 261:25-28. CrossRef Medline
47. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP (2010) Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68:368 -376. CrossRef Medline
48. Naruse I, KeinoH (1995) Apoptosis in the developing CNS. Prog Neurobiol 47:135-155. CrossRef Medline
49. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S (2000) Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 113:3073-3084. Medline
50. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, Carvill G, Kumar A, Lee C, Ankenman K, Munson J, Hiatt JB, Turner EH, Levy R, O'Day DR, Krumm N, Coe BP, Martin BK, Borenstein E, Nickerson DA, et al. (2012) Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338:1619 -1622. CrossRef Medline
51. Page DT, Kuti OJ, Prestia C, SurM (2009) Haploinsufficiency for Pten and serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A 106:1989 -1994. CrossRef Medline
52. Piven J, Arndt S, Bailey J, Andreasen N (1996) Regional brain enlargement in autism: a magnetic resonance imaging study. J AmAcad Child Adolesc Psychiatry 35:530 -536. CrossRef Medline
53. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563-1568. CrossRef Medline
54. Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM (2003) PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 23:6139-6149. CrossRef Medline
55. Raznahan A, Wallace GL, Antezana L, Greenstein D, Lenroot R, Thurm A, Gozzi M, Spence S, Martin A, Swedo SE, Giedd JN (2013) Compared to what? Early brain overgrowth in autism and the perils of population norms. Biol Psychiatry 74:563-575. CrossRef Medline
56. Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, Corneloup C, Richard-Bulteau H, Vignaud A, Baas D, Defour A, Freyssenet D, Tanti JF, Le-Marchand-Brustel Y, Ferrier B, Conjard-Duplany A, Romanino K, Bauché S, Hantaï D, Mueller M, Kozma SC, et al. (2009) Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J Cell Biol 187:859 - 874. CrossRef Medline
57. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, Pierce K, Hagler D, Schork N, Lord C, Courchesne E (2010) Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci 30:4419-4427. CrossRef Medline
58. Stambolic V (2002) PTEN: a new twist on beta-catenin? Trends Pharmacol Sci 23:104 -106. CrossRef Medline
59. Stessman HA, Bernier R, Eichler EE (2014) A genotype-first approach to defining the subtypes of a complex disease. Cell 156:872- 877. CrossRef Medline
60. Stiles B, Groszer M, Wang S, Jiao J, Wu H (2004) PTENless means more. Dev Biol 273:175-184. CrossRef Medline
61. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/ protein kinase B signaling pathway. Proc Natl Acad Sci U S A 96:6199- 6204. CrossRef Medline
62. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, Tsuchiya KJ, Iwata Y, Tsujii M, Sugiyama T, Mori N (2013) Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70:49 -58. CrossRef Medline
63. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, et al. (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225. Medline
64. Thompson BA, Tremblay V, Lin G, Bochar DA (2008) CHD8 is an ATPdependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol 28:3894 -3904. CrossRef Medline
65. Varga EA, Pastore M, Prior T, Herman GE, McBride KL (2009) The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11: 111-117. CrossRef Medline
66. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67- 81. CrossRef Medline
67. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380- 384. CrossRef Medline
68. Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD, Dawson G, Piven J (2007) Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 64:709 -717. CrossRef Medline
69. Yokoo H, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K, Kamiya M, Sasaki A, Hirato J, Nakazato Y (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717-1725. CrossRef Medline
70. Zeidán-Chuliá F, Salmina AB, Malinovskaya NA, Noda M, Verkhratsky A, Moreira JC (2014) The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 38:160 -172. CrossRef Medline
71. Zhou J, Parada LF (2012) PTEN signaling in autism spectrum disorders. Curr Opin Neurobiol 22:873- 879. CrossRef Medline
72. Zilbovicius M, Garreau B, Samson Y, Remy P, Barthélémy C, Syrota A, Lelord G (1995) Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry 152:248 -252. CrossRef Medline